Written and medically reviewed by Dr. Mohanad Diab, Consultant Medical Oncologist, Mediclinic Abu Dhabi.
Multiple Myeloma Treatment in Abu Dhabi
Multiple myeloma is a blood cancer affecting plasma cells in the bone marrow. It is notably more common in the Middle East and Gulf region.
Understanding Multiple Myeloma
Cancer of the plasma cells (a type of white blood cell)Produces abnormal proteins that damage bones and kidneysMore common in adults over 60, but can occur earlier in the Middle EastCommon Symptoms
Bone pain (especially back and ribs)Fatigue and weaknessFrequent infectionsKidney problemsUnexplained weight lossLatest Treatment Options
1. Induction Therapy
VRd protocol: (Bortezomib + Lenalidomide + Dexamethasone) — gold standardUsually 4-6 cycles over 4-6 months2. Stem Cell Transplant
Recommended for eligible patients under 70Dr. Diab trained in BMT at Radiumhemmet, Stockholm3. Immunotherapy
Daratumumab: (anti-CD38) — revolutionary for myelomaOften combined with other drugs4. Maintenance Therapy
Lenalidomide: — extends remission by yearsLiving with Multiple Myeloma
Many patients live 10+ years with proper treatmentTreatment evolving rapidly with new drugs every yearQuality of life can be maintainedDr. Diab's Myeloma Expertise
BMT-trained at Radiumhemmet, StockholmTreated hundreds of myeloma patients across Europe and UAELatest European protocolsMultidisciplinary team coordinationDiagnosed with multiple myeloma? Schedule a consultation with Dr. Mohanad Diab at Mediclinic Abu Dhabi.